相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Insulin analogues and cancer risk: cause for concern or cause celebre?
M. Pollak et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases?
Terry J. Smith
PHARMACOLOGICAL REVIEWS (2010)
IGF-1, oxidative stress and atheroprotection
Yusuke Higashi et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Treatment with insulin glargine (Lantus®) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells
Doris Mayer et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2010)
Perspectives in mammalian IGFBP-3 biology: local vs. systemic action
Paulette M. Yamada et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells
Doron Weinstein et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
Antonino Belfiore et al.
ENDOCRINE REVIEWS (2009)
The Role of Liver-Derived Insulin-Like Growth Factor-I
Claes Ohlsson et al.
ENDOCRINE REVIEWS (2009)
Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines
Ashish Shukla et al.
ENDOCRINE-RELATED CANCER (2009)
Mechanisms Mediating Brain Plasticity: IGF1 and Adult Hippocampal Neurogenesis
Maria LLorens-Martin et al.
NEUROSCIENTIST (2009)
Role of IGF-I in skeletal muscle mass maintenance
David R. Clemmons
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
The GH-IGF-I axis and the cardiovascular system: clinical implications
Annamaria Colao
CLINICAL ENDOCRINOLOGY (2008)
Proliferation of Colo-357 pancreatic carcinoma cells and survival of patients with pancreatic carcinoma are not altered by insulin glargine
Saskia Erbel et al.
DIABETES CARE (2008)
Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and IGF-I
E. Liefvendahl et al.
HORMONE AND METABOLIC RESEARCH (2008)
The role of IGF-system in vascular insulin resistance
H. J. Arnqvist
HORMONE AND METABOLIC RESEARCH (2008)
IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop
Hongxia Ren et al.
JOURNAL OF CELL BIOLOGY (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Review:: The somatomedin hypothesis 2007: 50 years later
Solomon A. Kaplan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts
K. Eckardt et al.
DIABETOLOGIA (2007)
Apoptosis and the cardiac action of insulin-like growth factor I
M.-S. Suleiman et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Comparison of the mitogenic potency of regular human insulin and its analogue glargine in normal and transformed human breast epithelial cells
K. Staiger et al.
HORMONE AND METABOLIC RESEARCH (2007)
Mechanisms of Disease: metabolic effects of growth hormone and insulin-like growth factor 1
Derek LeRoith et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults
K. C. J. Yuen et al.
DIABETES OBESITY & METABOLISM (2007)
Involvement of insulin-like growth factor-I in the control of glucose homeostasis
David R. Clemmons
CURRENT OPINION IN PHARMACOLOGY (2006)
Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes
Tero Saukkonen et al.
DIABETES (2006)
Insulin and its analogue glargine do not affect viability and proliferation of human coronary artery endothelial and smooth muscle cells
K Staiger et al.
DIABETOLOGIA (2005)
Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose
DR Clemmons et al.
GROWTH HORMONE & IGF RESEARCH (2005)
Are the metabolic effects of GH and IGF-I separable?
N Mauras et al.
GROWTH HORMONE & IGF RESEARCH (2005)
Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells
HS Kim et al.
CANCER RESEARCH (2004)
Insulin-like growth factors and neoplasia
MN Pollak et al.
NATURE REVIEWS CANCER (2004)
Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells
SI Chisalita et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Cellular actions of the insulin-like growth factor binding proteins
SM Firth et al.
ENDOCRINE REVIEWS (2002)
Serum insulin-like growth factor I regulates brain amyloid-levels
E Carro et al.
NATURE MEDICINE (2002)
Insulin-like growth factor-II/mannose 6-phosphate receptor overexpression reduces growth of choriocarcinoma cells in vitro and in vivo
DB O'Gorman et al.
ENDOCRINOLOGY (2002)
The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves huntingtin phosphorylation by Akt
S Humbert et al.
DEVELOPMENTAL CELL (2002)
Evaluation of the carcinogenic potential of insulin glargine (LANTUS) in rats and mice
I Stammberger et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2002)
Increases in free, unbound insulin-like growth factor I enhance insulin responsiveness in human hepatoma G2 cells in culture
K Sakai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice
S Welch et al.
CIRCULATION RESEARCH (2002)
An exonic splicing enhancer in human IGF-I pre-mRNA mediates recognition of alternative exon 5 by the serine-arginine protein splicing factor-2/alternative splicing factor
PJ Smith et al.
ENDOCRINOLOGY (2002)
Effects of the long-acting insulin analog insulin glargine on cultured human skeletal muscle cells: Comparisons to insulin and IGF-I
TP Ciaraldi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
The somatomedin hypothesis: 2001
D Le Roith et al.
ENDOCRINE REVIEWS (2001)
IGF-1 receptor as an alternative receptor for metabolic signaling in insulin receptor-deficient muscle cells
A Baudry et al.
FEBS LETTERS (2001)
Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance
K Cusi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use
P Kurtzhals et al.
DIABETES (2000)
The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes:: Evidence for in vivo biological activity
DR Clemmons et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
分享论文
